Content about GREENSBORO

February 13, 2014

Merz North America recently launched Mederma PM, a new one-of-a-kind scar cream formulated to work at night, when skin naturally regenerates faster.

January 9, 2014

As a brand that got into the business on the ground floor, blu is positioned to continue its role as a major player in the electronic cigarette category.

October 10, 2013

A new strength of a drug for athlete's foot made by Merz Pharma Group has become available, the company said Thursday.

February 21, 2013

Men and women have complex and often different views about how their skin imperfections affect their appearance and confidence, according to a new survey.

February 4, 2013

Merz North America on Monday named Jim Hartman VP of the Merz Aesthetics business unit, which includes Xeomin, Radiesse and Belotero Balance.

August 28, 2012

Merz announced it has acquired a medication designed to treat a condition associated with such neurologic conditions as cerebral palsy.

July 18, 2012

Food Lion has implemented its new brand strategy in the retailer's North Carolina and South Carolina stores.

July 9, 2012

Merz has promoted one of its executives to serve as VP and chief compliance officer.

March 19, 2012

Mederma, a maker of scar therapy products, has introduced its new Mederma advanced scar gel, which is designed to reduce the overall appearance of scars caused by injury, acne, surgery or burns with one daily application.

November 4, 2011

South of France Natural Body Care is launching a social media campaign anchored by its new blog, TheSoapDishMagazine.com, which went live Friday.

August 19, 2011

Five tobacco companies filed suit against the Food and Drug Administration challenging nine new cigarette warnings as an unconstitutional way of forcing tobacco manufacturers to disseminate the government's anti-smoking message.

July 20, 2011

Lorillard has voluntarily recalled certain Newport non-menthol cigarettes.

March 8, 2011

GREENSBORO, N.C. — Merz Pharmaceuticals has created two programs to provide financial assistance to patients using its drug for cervical dystonia, the company said Tuesday.

The programs — the Xeomin patient co-payment program and the Xeomin patient assistance program — cover Xeomin (incobotulinumtoxinA), designed to decrease the severity of abnormal head positions and neck pains in patients with the disease, which causes muscle contractions resulting in repetitive movements and abnormal postures.

August 1, 2010

The Food and Drug Administration has approved a treatment for muscle spasms and twitches....

© 2014 Drug Store News. All Rights Reserved.